Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model

gan Hines, Philip A., Guy, Richard H., Brand, Angela, Humphreys, Anthony J., Papaluca‐Amati, Marisa
Cyhoeddwyd yn Br J Clin Pharmacol (2019)

Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation

gan Eichler, Hans‐Georg, Koenig, Franz, Arlett, Peter, Enzmann, Harald, Humphreys, Anthony, Pétavy, Frank, Schwarzer‐Daum, Brigitte, Sepodes, Bruno, Vamvakas, Spiros, Rasi, Guido
Cyhoeddwyd yn Clin Pharmacol Ther (2019)

Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth

gan Eichler, Hans‐Georg, Pignatti, Francesco, Schwarzer‐Daum, Brigitte, Hidalgo‐Simon, Ana, Eichler, Irmgard, Arlett, Peter, Humphreys, Anthony, Vamvakas, Spiros, Brun, Nikolai, Rasi, Guido
Cyhoeddwyd yn Clin Pharmacol Ther (2020)

Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy

gan Hines, Philip A., Gonzalez-Quevedo, Rosa, Lambert, Apolline I. O. M., Janssens, Rosanne, Freischem, Barbara, Torren Edo, Jordi, Claassen, Ivo J. T. M., Humphreys, Anthony J.
Cyhoeddwyd yn Front Med (Lausanne) (2020)